post-add

Articles for doctors

RGCIRC Launches Palliative Care Support Group For Cancer Patients To Foster Compassionate Communities

Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) hosted the second Annual Palliative & Hospice Care Educational Symposium (PACES 2024) at Gulmohar Club, Delhi, bringing together cancer survivors, patients, and healthcare experts to highlight the crucial role of palliative care in cancer treatment.

Read More
India Joins International Medical Device Regulators Forum as Affiliate Member

In a significant move, India has become an affiliate member of the International Medical Device Regulators Forum (IMDRF), a global group focused on harmonising medical device regulations, the Union Health Ministry announced on Thursday.

Read More
CK Birla Hospital Performs Bilateral Hip Replacement On 65-Year-Old Woman Weighing 23kg

In a medical achievement, CK Birla Hospital, Delhi successfully performed India’s low-weight bilateral hip replacement surgery on a 65-year-old woman weighing just 23 kg.

Read More
RGCIRC Marks 28 Years Of Cancer Care Excellence, Announces Expansion Plans

The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) has announced plans to expand its operations across the National Capital Region (NCR) to provide quality cancer treatment to more people.

Read More
In Memoriam: Dr Sandip Chatterjee, Renowned Neurosurgeon and Advocate, Passes Away

It is with deep sadness that we announce the passing of Dr Sandip Chatterjee, one of India’s most esteemed neurosurgeons, and a remarkable human being

Read More
ENTOD Pharmaceuticals Seeks Reinstatement of Approval for Its Eye Drops Following Suspension by DCGI

Mumbai-based ENTOD Pharmaceuticals is working with the Drug Controller General of India (DCGI) to address concerns over its recently approved Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25per cent w/v, branded as PresVu eye drops. Approved on August 6 for the treatment of presbyopia in adults, the drug's approval was suspended by DCGI on September 10 after healthcare professionals raised concerns.

Read More
ICMR Report Warns of Rising Antibiotic Resistance In UTIs, Typhoid, And Pneumonia

The report examined 99,492 samples from public and private healthcare facilities across the country. These samples, collected from areas such as the blood, urine, and respiratory tract, were tested against bacteria like E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus.

Read More
AstraZeneca India Receives CDSCO Nod For Additional Indication Of Durvalumab In Lung Cancer Treatment

According to the GLOBOCAN 2022 data, lung cancer is the fourth leading cause of cancer-related mortality in India. NSCLC accounts for a significant proportion of these cases, with about 15 per cent of patients having resectable disease, this data underscores the importance of targeted treatment options.

Read More
Health Ministry’s 100 Days Program: A Leap Toward Health Innovation and Pandemic Preparedness

The Department of Health Research (DHR), under the Union Health Ministry, has successfully rolled out its ambitious 100 Days Program, marking significant strides in healthcare innovation, pandemic readiness, and the promotion of indigenous medical technologies.

Read More
Aster DM Healthcare To Invest Rs 220 Crore For Women And Children’s Hospital In Hyderabad

Aster DM Healthcare has announced plans to launch the largest Women & Children’s Hospital in Hyderabad. The state-of-the-art facility, spanning 3 lakh square feet, will feature 300 beds and offer advanced care for women and children.

Read More

Subscribe to our newsletter to get updates on our latest news